4//SEC Filing
LeBuhn Richard T. 4
Accession 0001140361-18-029807
CIK 0001572552other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:47 PM ET
Size
11.5 KB
Accession
0001140361-18-029807
Insider Transaction Report
Form 4
LeBuhn Richard T.
Director
Transactions
- Award
Stock Options
2018-06-21+20,000→ 20,000 totalExercise: $1.75Exp: 2028-06-21→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Option
Exercise: $3.45From: 2017-03-31Exp: 2027-03-29→ Common Stock (20,000 underlying) - 20,000
Stock Option
Exercise: $6.22From: 2015-07-09Exp: 2020-03-31→ Common Stock (20,000 underlying) - 25,000
Series A Common Stock
- 7,500
Warrants
Exercise: $4.37From: 2016-05-13Exp: 2021-05-13→ Common Stock (7,500 underlying) - 20,000
Stock Option
Exercise: $2.34From: 2014-08-19Exp: 2019-03-31→ Common Stock (20,000 underlying) - 20,000
Stock Options
Exercise: $3.64From: 2016-03-31Exp: 2026-02-28→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeother
Related Parties
1- filerCIK 0001428664
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:47 PM ET
- Size
- 11.5 KB